HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Intestinal Lymphangiectasis

Dilatation of the intestinal lymphatic system usually caused by an obstruction in the intestinal wall. It may be congenital or acquired and is characterized by DIARRHEA; HYPOPROTEINEMIA; peripheral and/or abdominal EDEMA; and PROTEIN-LOSING ENTEROPATHIES.
Also Known As:
Lymphangiectasis, Intestinal; Intestinal Lymphangiectases; Lymphangiectases, Intestinal
Networked: 8 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Protein-Losing Enteropathies (Protein-Losing Enteropathy)
2. Lymphoma (Lymphomas)
3. Lipidoses

Experts

1. Navacchia, Daniel: 1 article (03/2015)
2. Sommaruga, Horacio: 1 article (03/2015)
3. Santarcángelo, Salomé Catalina: 1 article (03/2015)
4. Quintana, Carlos: 1 article (03/2015)
5. Hill, Georgette D: 1 article (06/2012)
6. Lieuallen, Warren G: 1 article (06/2012)
7. Boyle, Michael C: 1 article (06/2012)
8. Painter, J Todd: 1 article (06/2012)
9. Crabbs, Torrie A: 1 article (06/2012)
10. Nyska, Abraham: 1 article (06/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Intestinal Lymphangiectasis:
1. Staphylococcal Protein A (A, Protein)IBA
2. Mebendazole (Vermin)FDA Link
3. CalciumIBA
4. Urioste Martinez-Frias syndromeIBA
5. indole-3-carbinolIBA

Therapies and Procedures

1. Parenteral Nutrition
2. Combination Drug Therapy (Combination Chemotherapy)
3. Diet Therapy (Therapy, Diet)